Malignant histiocytosis (true histiocytic lymphoma) clinicopathological study of 25 cases. 1985

S Pileri, and P Mazza, and M T Rivano, and G Martinelli, and G Cavazzini, and M Gobbi, and D Taruscio, and F Lauria, and S Tura

Twenty-five cases originally diagnosed as malignant histiocytosis/true histiocytic lymphoma were reviewed according to both pathological and clinical criteria. Microscopically, they were characterized by large, pleomorphic tumour cells showing variable degrees of atypia and phagocytic activity. The growth more often appeared as diffuse, being limited to the sinuses in only two cases. Cytochemistry on touch imprints showed tumour cells strongly positive for acid phosphatase and alpha-naphthyl-acetate esterase in all the samples tested. Immunohistochemistry on paraffin embedded sections using specific antisera showed tumour cell positivity for lysozyme in 12 of 25 cases, for alpha 1-antitrypsin in 24 of 25 cases and for alpha 1-antichymotrypsin in all 25 cases. Immunophenotyping on frozen-sections in three cases displayed a clear-cut reactivity of the neoplastic cells with the monoclonal antibody OKM1. Clinically, the disease more often presented with B-symptoms, lymphadenopathy and mediastinal involvement. In the majority of the patients (18/25) it had a fatal and rapid course, despite therapy (median survival: 9 months; mean survival: 12 months). The presence of B-symptoms and bulky disease appeared as the only factors influencing the prognosis, both suggesting a more aggressive course of the tumour.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D016403 Lymphoma, Large B-Cell, Diffuse Malignant lymphoma composed of large B lymphoid cells whose nuclear size can exceed normal macrophage nuclei, or more than twice the size of a normal lymphocyte. The pattern is predominantly diffuse. Most of these lymphomas represent the malignant counterpart of B-lymphocytes at midstage in the process of differentiation. Diffuse Large B-Cell Lymphoma,Diffuse, Large B-Cell, Lymphoma,Histiocytic Lymphoma, Diffuse,Lymphoma, Histiocytic, Diffuse,Diffuse Large-Cell Lymphoma,Histiocytic Lymphoma,Large Lymphoid Lymphoma, Diffuse,Large-Cell Lymphoma, Diffuse,Lymphoma, Diffuse Large-Cell,Lymphoma, Histiocytic,Lymphoma, Large Cell, Diffuse,Lymphoma, Large Lymphoid, Diffuse,Lymphoma, Large-Cell, Diffuse,Diffuse Histiocytic Lymphoma,Diffuse Histiocytic Lymphomas,Diffuse Large B Cell Lymphoma,Diffuse Large Cell Lymphoma,Diffuse Large-Cell Lymphomas,Histiocytic Lymphomas,Large Cell Lymphoma, Diffuse,Lymphoma, Diffuse Histiocytic,Lymphoma, Diffuse Large Cell

Related Publications

S Pileri, and P Mazza, and M T Rivano, and G Martinelli, and G Cavazzini, and M Gobbi, and D Taruscio, and F Lauria, and S Tura
January 1984, Histopathology,
S Pileri, and P Mazza, and M T Rivano, and G Martinelli, and G Cavazzini, and M Gobbi, and D Taruscio, and F Lauria, and S Tura
June 1991, The American journal of pathology,
S Pileri, and P Mazza, and M T Rivano, and G Martinelli, and G Cavazzini, and M Gobbi, and D Taruscio, and F Lauria, and S Tura
November 1988, Cancer,
S Pileri, and P Mazza, and M T Rivano, and G Martinelli, and G Cavazzini, and M Gobbi, and D Taruscio, and F Lauria, and S Tura
August 1988, Nederlands tijdschrift voor geneeskunde,
S Pileri, and P Mazza, and M T Rivano, and G Martinelli, and G Cavazzini, and M Gobbi, and D Taruscio, and F Lauria, and S Tura
January 1982, Indian journal of cancer,
S Pileri, and P Mazza, and M T Rivano, and G Martinelli, and G Cavazzini, and M Gobbi, and D Taruscio, and F Lauria, and S Tura
January 1981, Virchows Archiv. A, Pathological anatomy and histology,
S Pileri, and P Mazza, and M T Rivano, and G Martinelli, and G Cavazzini, and M Gobbi, and D Taruscio, and F Lauria, and S Tura
January 1983, Cancer,
S Pileri, and P Mazza, and M T Rivano, and G Martinelli, and G Cavazzini, and M Gobbi, and D Taruscio, and F Lauria, and S Tura
February 2004, Journal of the American Academy of Dermatology,
S Pileri, and P Mazza, and M T Rivano, and G Martinelli, and G Cavazzini, and M Gobbi, and D Taruscio, and F Lauria, and S Tura
April 1993, Journal of cutaneous pathology,
S Pileri, and P Mazza, and M T Rivano, and G Martinelli, and G Cavazzini, and M Gobbi, and D Taruscio, and F Lauria, and S Tura
July 1986, Acta pathologica, microbiologica, et immunologica Scandinavica. Section A, Pathology,
Copied contents to your clipboard!